Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Platelet Receptor Recognition Domains On The Alpha Chain Of Human Fibrinogen: Structure-function Analysis.

J. Hawiger, M. Kloczewiak, M. Bednarek, S. Timmons
Published 1989 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
We have previously shown that the alpha chain of human fibrinogen interacts directly with ADP-activated human platelets [Hawiger, J., Timmons, S., Kloczewiak, M., Strong, D. D., & Doolittle, R. F. (1982) Proc. Natl. Acad. Sci. U.S.A. 79, 2068]. Now, we report that platelet receptor recognition domains are localized on two CNBr fragments of the human fibrinogen alpha chain. They encompass residues 92-147 and 518-584, which inhibit 125I-fibrinogen binding to ADP-stimulated platelets. The inhibitory CNBr fragment alpha 92-147 contains the RGD sequence at residues 95-97. Synthetic peptides encompassing this sequence were inhibitory while peptide 99-113 lacking the RGD sequence was inactive. The synthetic peptide RGDF, corresponding to residues alpha 95-98, inhibited the binding of 125I-fibrinogen to ADP-treated platelets (IC50 = 2 microM). However, the peptides containing sequence RGDF, with residues preceding Arg95 or following Phe98, were less inhibitory. It appears that the sequence alpha 95-98 constitutes a platelet receptor recognition domain which is constrained by flanking residues. The second inhibitory CNBr fragment, alpha 518-584, also contains the sequence RGD at positions 572-574. Synthetic peptides overlapping this sequence were inhibitory, while peptides lacking the sequence RGDS were not reactive. Thus, another platelet reactive site on the alpha chain encompasses residues 572-575 containing sequence RGDS. In conclusion, the platelet receptor recognition domains on the human fibrinogen alpha chain in the amino-terminal and in the carboxy-terminal zones contain the ubiquitous cell recognition sequence RGD shared with other known adhesive proteins.(ABSTRACT TRUNCATED AT 250 WORDS)
This paper references
10.1146/ANNUREV.BI.53.070184.001211
Fibrinogen and fibrin.
R. Doolittle (1984)
10.1016/0092-8674(87)90233-9
Integrins: A family of cell surface receptors
R. Hynes (1987)
Evidence that Na+/H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets.
J. Sweatt (1986)
10.1021/BI00278A003
Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientation.
P. D. Hoeprich (1983)
10.1172/JCI104721
IN VIVO BEHAVIOR OF I131-FIBRINOGEN
A. S. Mcfarlane (1963)
10.1126/SCIENCE.2821619
New perspectives in cell adhesion: RGD and integrins.
E. Ruoslahti (1987)
10.1126/SCIENCE.4071058
A model for fibrinogen: domains and sequence.
J. Weisel (1985)
10.1021/BI00303A028
Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain.
M. Kloczewiak (1984)
10.1073/PNAS.82.23.8057
The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets.
E. Plow (1985)
10.1073/PNAS.83.23.9197
Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.
H. Banga (1986)
10.1182/BLOOD.V49.4.635.BLOODJOURNAL494635
Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation
S. Niewiarowski (1977)
10.1182/BLOOD.V70.1.110.BLOODJOURNAL701110
Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets.
E. Plow (1987)
10.1016/0049-3848(79)90090-2
The ability of fibrinogen fragments to support ADP-induced platelet aggregation.
J. Holt (1979)
Fine structure of the bond between platelets in artificial thrombi and in platelet aggregates induced by adenosine diphosphate.
K. Shirasawa (1969)
10.1182/BLOOD.V67.2.385.385
Fibrinogen binding to human blood platelets: effect of gamma chain carboxyterminal structure and length.
E. Peerschke (1986)
10.1182/BLOOD.V64.6.1163.BLOODJOURNAL6461163
Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets
E. Harfenist (1984)
10.1182/BLOOD.V70.2.558.558
ADP-induced platelet aggregation depends on the conformation or availability of the terminal gamma chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris 1.
M. H. Denninger (1987)
10.1038/309030A0
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
M. Pierschbacher (1984)
10.1016/0092-8674(85)90101-1
Interaction of fibronectin with its receptor on platelets
J. Gardner (1985)
10.1016/s0021-9258(18)45247-7
Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa.
L. Parise (1987)
10.1016/0049-3848(78)90300-6
Separation of human platelets from plasma proteins including factor VIII VWF by a combined albumin gradient-gel filtration method using HEPES buffer.
S. Timmons (1978)
10.1083/JCB.104.6.1655
The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering
W. Isenberg (1987)
10.1083/JCB.104.3.585
A cell surface receptor complex for collagen type I recognizes the Arg- Gly-Asp sequence
S. Dedhar (1987)
10.1016/s0021-9258(18)89211-0
Inhibition of fibronectin binding to platelets by proteolytic fragments and synthetic peptides which support fibroblast adhesion.
M. Ginsberg (1985)
10.1073/PNAS.81.15.4935
ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
S. Timmons (1984)
10.1016/s0021-9258(17)38962-7
The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
T. K. Gartner (1985)
10.1016/0006-291X(76)90895-0
The amino acid sequence of a 27-residue peptide released from the alpha-chain carboxy-terminus during the plasmic digestion of human fibrinogen.
B. Cottrell (1976)
10.1073/PNAS.79.6.2068
gamma and alpha chains of human fibrinogen possess sites reactive with human platelet receptors.
J. Hawiger (1982)
10.1038/280464a0
The amino acid sequence of the α-chain of human fibrinogen
R. Doolittle (1979)
10.1182/BLOOD.V69.3.950.BLOODJOURNAL693950
The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets
E. I. Peerschke (1987)
10.1016/S0076-6879(83)91038-8
High-sensitivity sequencing with a gas-phase sequenator.
M. Hunkapiller (1983)
10.1182/BLOOD.V66.4.946.BLOODJOURNAL664946
Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin.
D. Haverstick (1985)



This paper is referenced by
Characterisation of cellular fibrinogen phosphorylation and its functional implications in clot formation
Esther J. Cooke (2015)
Are integrins involved in the aggregatory and phagocytic behaviour of fish haemostatic cells?
D. Hill (1998)
10.1111/J.1432-1033.1997.00416.X
Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen.
D. McDevitt (1997)
Biological effects of extracellular fibrinogen binding protein (Efb) in staphylococcus aureus infection
O. Shannon (2005)
10.1517/13543784.4.5.413
Section Review—Cardiovascular & Renal: Integrins and Cardiovascular Disease
D. Cox (1995)
10.1016/0014-5793(95)01144-4
A novel approach to the design of potent bioactive peptides by incorporation of proline brackets: antiplatelet effects of Arg‐Gly‐Asp peptides
R. Manjunatha Kini (1995)
10.3390/molecules25173890
Blood Clot Phenotyping by Rheometry: Platelets and Fibrinogen Chemistry Affect Stress-Softening and -Stiffening at Large Oscillation Amplitude
U. Windberger (2020)
10.1007/978-1-4615-5049-5_14
Platelet Biorheology: Adhesive Interactions in Flow
M. M. Frojmovic (1999)
10.1016/0968-0896(95)00036-G
Antithrombotic agents: from RGD to peptide mimetics.
I. Ojima (1995)
Structural and functional analysis of Staphylococcus aureus immune evasion proteins
Elizabeth A. Clark (2009)
10.1016/1040-8428(93)90053-7
Molecular and cellular biology of integrins.
D. Tuckwell (1993)
10.1111/j.1365-2958.2010.07510.x
Leptospira immunoglobulin‐like protein B (LigB) binding to the C‐terminal fibrinogen αC domain inhibits fibrin clot formation, platelet adhesion and aggregation
Y. Lin (2011)
10.1016/S0049-3848(98)00080-2
Characterization of the binding of FK633 to the platelet fibrinogen receptor.
D. Cox (1998)
10.1016/J.MOLSTRUC.2019.07.063
Development and activity evaluation of Arg-Gly-Asp-containing antithrombotic conjugate
Chen Shuangling (2019)
protein (Efb) in Staphylococcus aureus infection
O. Shannon (2005)
10.15407/UBJ88.SI01.079
Mapping of residues of fibrinogen cleaved by protease II of Bacillus thuringiensis var. israelensis IMV B-7465
E. M. Stohniy (2016)
10.1016/0041-0101(90)90155-Z
Effects of snake venom proteins on blood platelets.
R. Kini (1990)
Interaction Of Leptospiral Microbial Surface Components Recognizing Adhesive Matrix Molecules With Host Extracellular Matrix
Yi Lin (2010)
to the interaction of human endothelial cells with extracellular matrix Reactivity of synthetic peptide analogs of adhesive proteins in regard
Cs Chen (2011)
10.1182/blood.v86.3.1001.1001
Evidence that fibrin alpha-chain RGDX sequences are not required for platelet adhesion in flowing whole blood.
R. Hantgan (1995)
10.1023/A:1008024924329
Elucidation of a common structure of selective fibrinogen receptor antagonists
H. Minoux (1998)
10.1371/journal.pone.0066901
Molecular Characterization of the Multiple Interactions of SpsD, a Surface Protein from Staphylococcus pseudintermedius, with Host Extracellular Matrix Proteins
G. Pietrocola (2013)
10.1016/0041-0101(96)00017-7
Insights into the mechanism of haemorrhage caused by snake venom metalloproteinases.
A. Kamiguti (1996)
10.1111/j.1537-2995.2007.01265.x
Prolonged hemostatic ability of polyethylene glycol–modified polymerized albumin particles carrying fibrinogen γ‐chain dodecapeptide
Y. Okamura (2007)
10.1182/blood.v77.10.2200.bloodjournal77102200
Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix.
C. Chen (1991)
10.1016/0741-5214(89)90148-1
Inhibition of adhesive receptors: Research initiatives in vascular surgery *
J. Hawiger (1989)
10.1182/BLOOD.V81.6.1505.BLOODJOURNAL8161505
Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation.
J. Kang (1993)
10.1016/S1058-6687(05)80028-2
Use of monoclonal antibodies to study the interaction between an integrin adhesion receptor, GP IIb-IIIa, and its physiological ligand, fibrinogen
S. Shattil (1992)
A pharmacological characterization of ADP receptors on human platelets
Hye-Seong. Park (2000)
10.1385/1-59259-404-2:107
Development and Use of Platelet Glycoprotein Antagonists in Heart Disease
J. Bennett (2003)
10.1182/BLOOD.V78.7.1744.1744
Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
M. H. Lee (1991)
10.1002/prot.20758
Natively unfolded regions of the vertebrate fibrinogen molecule
R. Doolittle (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar